dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Romero, Octavio A. |
dc.contributor.author | Vilarrubi, Andrea |
dc.contributor.author | Alburquerque-Bejar, Juan J. |
dc.contributor.author | Gomez Moruno, Antonio |
dc.contributor.author | Andrades, Alvaro |
dc.contributor.author | Trastulli, Deborah |
dc.contributor.author | Oaknin Benzaquen, Ana Mazaltob |
dc.date.accessioned | 2022-01-27T09:50:20Z |
dc.date.available | 2022-01-27T09:50:20Z |
dc.date.issued | 2021-07-14 |
dc.identifier.citation | Romero OA, Vilarrubi A, Alburquerque-Bejar JJ, Gomez A, Andrades A, Trastulli D, et al. SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade. Nat Commun. 2021 Jul 14;12:4319. |
dc.identifier.issn | 2041-1723 |
dc.identifier.uri | https://hdl.handle.net/11351/6911 |
dc.description | Teràpia del càncer |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | Nature Communications;12 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Càncer - Tractament |
dc.subject | Resistència als medicaments |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Drug Resistance, Neoplasm |
dc.title | SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41467-021-24618-3 |
dc.subject.decs | neoplasias |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | resistencia a los antineoplásicos |
dc.relation.publishversion | https://doi.org/10.1038/s41467-021-24618-3 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Romero OA, Vilarrubi A, Alburquerque-Bejar JJ] Cancer Genetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain. [Gomez A] Grup de Recerca en Reumatologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Andrades A] Department of Biochemistry and Molecular Biology I. Faculty of Sciences, University of Granada, Granada, Spain. GENYO. Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, Granada, Spain. [Trastulli D] Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL Barcelona, Barcelona, Spain. [Oaknin A] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 34262032 |
dc.identifier.wos | 000675630200001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |